» Articles » PMID: 27650838

Accessibility and Barriers to Oncology Appointments at 40 National Cancer Institute-Designated Comprehensive Cancer Centers: Results of a Mystery Shopper Project

Overview
Journal J Oncol Pract
Specialty Oncology
Date 2016 Sep 22
PMID 27650838
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Patients turn to National Cancer Institute (NCI) -designated comprehensive cancer centers because of perceived better quality and more timely access to care. However, recent studies have found that patients at various institutions may struggle to gain access to an appointment or obtain consistent information from attendants. Our study employs a mystery shopper format to identify and quantify barriers faced by patients seeking to make a first consultation appointment across a homogenous sample of 40 NCI-designated comprehensive cancer centers.

Methods: Five mystery shoppers used a standardized call script to inquire about first available appointment times and service offerings.

Results: When inquiring about a date for a first available appointment, 29% of callers were unable to secure an estimated date without registering into the center's database, 51% were able to secure an estimated date, and 20% were provided with an actual date. Of estimated or actual dates for a first available appointment, 74% were greater than 1 week away. There was no statistically significant variation between appointment availability across insurance type or US region.

Conclusion: Our study highlights the difficulty of accessing information about appointment availability. Although not statistically significant, inquiries regarding first available appointments for Medicaid patients resulted in longer estimated or actual wait times than those for patients with private insurance, and Medicaid shoppers noted qualitative differences. Although our study was limited by small sample size and imperfect analytic methods, our results suggest the need for more efficient and accessible care for patients at our nation's top cancer centers.

Citing Articles

Impact of COVID-19 on Gynecologic Oncology Wait Times: A Mystery Caller Study.

Lemieux M, Turner K, Durfee J, Mastroyannis S, Muffly T Cureus. 2024; 16(10):e72328.

PMID: 39583346 PMC: 11585481. DOI: 10.7759/cureus.72328.


Institutional barriers to clinical trial exploration experienced by the Latinx community.

Sandoval S, Leung R, Nguyen-Grozavu F, Wang R, Sadler G J Cancer Educ. 2023; 38(4):1271-1276.

PMID: 37118405 PMC: 10366247. DOI: 10.1007/s13187-022-02259-4.


Acceptance of Simulated Adult Patients With Medicaid Insurance Seeking Care in a Cancer Hospital for a New Cancer Diagnosis.

Marks V, Hsiang W, Nie J, Demkowicz P, Umer W, Haleem A JAMA Netw Open. 2022; 5(7):e2222214.

PMID: 35838668 PMC: 9287756. DOI: 10.1001/jamanetworkopen.2022.22214.


Usability of PCforMe in Patients With Advanced Cancer Referred to Outpatient Palliative Care: Results of a Randomized, Active-Controlled Pilot Trial.

Kamal A, Wolf S, Nicolla J, Friedman F, Xuan M, Bennett A J Pain Symptom Manage. 2019; 58(3):382-389.

PMID: 31163259 PMC: 10230646. DOI: 10.1016/j.jpainsymman.2019.05.007.


Medicaid Patients Have Greater Difficulty Scheduling Health Care Appointments Compared With Private Insurance Patients: A Meta-Analysis.

Hsiang W, Lukasiewicz A, Gentry M, Kim C, Leslie M, Pelker R Inquiry. 2019; 56:46958019838118.

PMID: 30947608 PMC: 6452575. DOI: 10.1177/0046958019838118.